Results 21 to 30 of about 18,910 (175)

Preparation and characterization of captopril loaded polycaprolactone electrospun nanofibers [PDF]

open access: yesNanomedicine Journal, 2023
Objective(s): Electrospun nanofibrous mats of Polycaprolactone (PCL) and amino modified SBA-15 containing Captopril were prepared and release of drug from prepared nanofibers were investigated in this study.Materials and Methods: Amino modified SBA-15 ...
Amir Doustgani   +2 more
doaj   +1 more source

Electrochemical and Computational Studies of Proline and Captopril as Corrosion Inhibitors on Carbon Steel in a Phase Change Material Solution

open access: yesInternational Journal of Electrochemical Science, 2020
In this paper, electrochemical and surface analysis methods were used to study the corrosion inhibition performance of proline and captopril on 1045 carbon steel in phase change materials (PCMs).
Wenwu Li   +5 more
doaj   +1 more source

Effects of captopril against radiation injuries in the Göttingen minipig model of hematopoietic-acute radiation syndrome.

open access: yesPLoS ONE, 2021
Our laboratory has demonstrated that captopril, an angiotensin converting enzyme inhibitor, mitigates hematopoietic injury following total body irradiation in mice.
W Bradley Rittase   +13 more
doaj   +1 more source

Captopril Pretreatment Produces an Additive Cardioprotection to Isoflurane Preconditioning in Attenuating Myocardial Ischemia Reperfusion Injury in Rabbits and in Humans

open access: yesMediators of Inflammation, 2015
Background. Pretreatment with the angiotensin-converting inhibitor captopril or volatile anesthetic isoflurane has, respectively, been shown to attenuate myocardial ischemia reperfusion (MI/R) injury in rodents and in patients.
Yi Tian   +6 more
doaj   +1 more source

Captopril versus enalapril in the protection of the gastric mucosa against NSAID induced gastric mucosal injury in rats

open access: yesمجلة كلية الطب, 2011
Background: Different mechanisms have been suggested for the development of nonsteroidal antiinflammatory drugs (NSAIDs) induced gastropathy. Angiotensin converting enzyme inhibitors have been suggested to have gastroprotective effects.
Samir Y. N. Matloub
doaj   +1 more source

Clinical Significance of Acute Kidney Injury in Idiosyncratic Drug‐Induced Liver Injury: A Multicentric Propensity Scores Matched Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Clinical significance of acute kidney injury in idiosyncratic drug‐induced liver injury: a multicentric propensity scores matched study. Evidence about the role of acute kidney injury (AKI) in idiosyncratic drug‐induced liver injury (DILI) is still scarce.
José María Pinazo‐Bandera   +15 more
wiley   +1 more source

Participation of kinins in the inhibitory action of captopril on acute hypertension induced by L-NAME in anesthetized rats

open access: yesBrazilian Journal of Medical and Biological Research, 1997
The aim of the present study was to investigate the role of bradykinin in the inhibitory action of captopril in hypertension induced by L-NAME in anesthetized rats.
R. Soares de Moura, M. Cardoso
doaj   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro   +15 more
wiley   +1 more source

Protective effect of captopril against methotrexate- induced nephrotoxicity in mice

open access: yesKufa Journal for Veterinary Medical Sciences, 2010
The present study was designed to investigate some histopathological changes produced by methotrexate on kidney in mice and extended to examine whether there using captopril have ability to reduce this toxicity.
Atiaf G. R. AL-Nailey
doaj   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy